Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

03 Jun 2021 Evaluate
Cadila Healthcare has informed that it enclosed a copy of press release dated June 3, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Osimertinib 
Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..